Developmental Mechanisms in Articular Cartilage Degradation in Osteoarthritis

被引:71
作者
Tchetina, Elena V. [1 ]
机构
[1] Russian Acad Med Sci, Inst Rheumatol, Kashirskoye Shosse 34A, Moscow 115522, Russia
基金
俄罗斯基础研究基金会;
关键词
D O I
10.1155/2011/683970
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Osteoarthritis is the most common arthritic condition, which involves progressive degeneration of articular cartilage. The most recent accomplishments have significantly advanced our understanding on the mechanisms of the disease development and progression. The most intriguing is the growing evidence indicating that extracellular matrix destruction in osteoarthritic articular cartilage resembles that in the hypertrophic zone of fetal growth plate during endochondral ossification. This suggests common regulatory mechanisms of matrix degradation in OA and in the development and can provide new approaches for the treatment of the disease by targeting reparation of chondrocyte phenotype.
引用
收藏
页数:16
相关论文
共 245 条
[1]
Developments in the scientific understanding of osteoarthritis [J].
Abramson, Steven B. ;
Attur, Mukundan .
ARTHRITIS RESEARCH & THERAPY, 2009, 11 (03)
[2]
Growth plate cartilage as developmental model in osteoarthritis research - Potentials and limitations [J].
Aigner, T. ;
Gerwin, N. .
CURRENT DRUG TARGETS, 2007, 8 (02) :377-385
[3]
Osteoarthritis: Aging of matrix and cells - Going for a remedy [J].
Aigner, T. ;
Haag, J. ;
Martin, J. ;
Buckwalter, J. .
CURRENT DRUG TARGETS, 2007, 8 (02) :325-331
[4]
Molecular pathology and pathobiology of osteoarthritic cartilage [J].
Aigner, T ;
McKenna, L .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (01) :5-18
[5]
Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO
[6]
2-H
[7]
Gene expression in chondrocytes assessed with use of microarrays [J].
Aigner, T ;
Zien, A ;
Hanisch, D ;
Zimmer, R .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A :117-123
[8]
Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P1304, DOI 10.1002/1529-0131(200106)44:6<1304::AID-ART222>3.0.CO
[9]
2-T
[10]
Akaogi Jun, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P383